Navigation Links
BD Announces Results for Fourth Fiscal Quarter and Full Year
Date:11/4/2009

United States -------------------------------- 2009 2008 % Change ---------- --------- --------- BD MEDICAL ---------- Medical Surgical Systems $1,021,846 $977,262 4.6 Diabetes Care 351,618 332,545 5.7 Pharmaceutical Systems 177,529 189,394 (6.3) Ophthalmic Systems 26,993 25,003 8.0 --------------------- ------ ------ --- TOTAL $1,577,986 $1,524,204 3.5 ----- ---------- ---------- --- BD DIAGNOSTICS -------------- Preanalytical Systems $608,754 $574,378 6.0 Diagnostic Systems 568,789 547,465 3.9 --------------------- ------- ------- --- TOTAL $1,177,543 $1,121,843 5.0 ----- ---------- ---------- --- BD BIOSCIENCES -------------- Cell Analysis $303,846 $324,698 (6.4) Discovery Labware 145,305 145,943 (0.4) -------------------- ------- ------- ---- TOTAL $449,151 $470,641 (4.6) ----- -------- -------- ---- TOTAL UNITED STATES $3,204,680 $3,116,688 2.8 ------------------- ---------- ---------- --- BECTON DICKINSON AND COMPANY SUPPLEMENTAL REVENUE INFORMATION REVENUES BY BUSINESS SEGMENTS AND UNITS Twelve Months Ended
'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...if., Nov. 30 StemCyte, Inc. conclu...eement with Academia Sinica, the National Laborato...Intellectual Property (IP) related to the treatmen...and IP was pioneered by a team led by Professor Jo...rofessor Lin is currently the exclusive collaborat...
(Date:11/30/2009)...LLS, Mich., Nov. 30 eHealthSource....ted exclusively to products approved for Flexible ...A) claims. The site is also the first to exclusiv...s, saving shoppers up to 75 percent on everyday he...wo common healthcare headaches - high costs and co...
(Date:11/30/2009)... Italy, November 30 Health Robotic... development plans and product specifications,for ...d Parenteral,Nutrition", a new key component of it...t Las Vegas, ASHP (Booth # 114). , "I loo...o the,TPNstation,s blueprints and to find out if T...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 1China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 2China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 1MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 4Obama Named the Most Powerful Person in Healthcare 55134 1Obama Named the Most Powerful Person in Healthcare 55134 2
...MELBOURNE, Australia, Feb. 11 Phosphagenics,Limit...PGNY) and Nestle,Nutrition (Nestle) today announce... establish the efficacy of Phosphagenics, Phospha ...vancing at three sites in Adelaide,Australia., Ba...ants, the,double-blind phase 2 trial, which is ful...
...BOULDER, Colo., and MONTREAL, Feb. 11 ,Pharmion (N...y announced that,the European Medicines Agency (EM...CD0103, a histone deacetylase (HDAC) inhibitor, as...acute myelogenous leukemia in the,European Union (...duct be,intended for the treatment of life-threate...
Other Medicine Technology:Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4
(Date:11/30/2009)... , SILVER SPRING, Md., Nov. 30 /PRNewsw...se consumers a bronzed body year-round, but the ul...serious health risks. ,, (Logo: http://www.ne...Although some people think that a tan gives them a..." says Sharon Miller, M.S.E.E., a Food and Drug Ad...
(Date:11/30/2009)... , CHICAGO, Nov. 30 Physicians...reported today on results of a study demonstrating...CT angiography (cCTA) by Rcadia,s COR Analyzer Sys... artery stenosis in hospital emergency department ... automated system to enhance the use of cCTA has p...
(Date:11/30/2009)... University of Navarra Hospital has launched a ser...cacy of an immunotherapy treatment. This approach ...produced from healthy and tumour cells from the pa...astomas, one of the most aggressive and frequent m...to participating patients combined with the standa...
(Date:11/30/2009)... Peter J. Rappa, MD, explores ...body in his new book "Healing Heart to Soul: ... Life" (Brown Books 2009). , ...Experiencing and refusing to let go of negative em...s, can weigh heavy on our shoulders. Oftentimes, t...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Re...h report is available in its catalogue: ,, Gen...rtunities ,, http://www.reportlinker.com/p016...pportunities.html ,, Gene therapy promises to...e. Although no significant achievements for curing...
Breaking Medicine News(10 mins):Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5
...nts , , MONDAY, Jan. 7 (HealthDay News) --...sunlight, some foods and supplements -- are assoc...blems such as heart attack and stroke, U.S. resear...sachusetts city. , The research team found that th...
...r Integrative Health Solutions for Te...Jan. 7 Gaiam, Inc., the,leading distributor of sp...nt of the fitness and wellness market, today annou... - obesity,type 2 diabetes, back pain, high blood ...
...ga AB, a subsidiary of Cambrex Corporation (NYSE: ... a purchase agreement for all of the stock,of ProS...ingredients,("API") research and development compa... a spin off from Tallinn University,of Technology,...
...r prescriptions, kept exam dates, study finds , ...buying contact lenses online may save time in the ...oper eye care, new research shows. , Time saved ...ale clubs or optical chains were also less likely ...
... at any given time, almost 10 percent of the emerg...the United States miss work because of injuries an...examining how common these injuries are and tracki...ponders will suffer an injury or illness forcing t...
...ARRISBURG, Pa., Jan. 7 Nutrition has moved up on ...cent) consider the nutritional,content of foods th...did,two to three years ago, says a new survey from...en,s nutrition., However, the battle between nutr...
Other Medicine News:Health News:Low Vitamin D Linked to Heart Risk 2Health News:Low Vitamin D Linked to Heart Risk 3Health News:Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic 2Health News:Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic 3Health News:Cambrex Signs Agreement To Acquire ProSyntest AS 2Health News:Eye Care Lacking in Many Who Buy Contact Lenses Online 2Health News:Emergency responders at high risk to miss work because of injuries 2Health News:Emergency responders at high risk to miss work because of injuries 3Health News:Nutrition Moves Up on Mom's Purchasing Agenda 2Health News:Nutrition Moves Up on Mom's Purchasing Agenda 3
...y EX.P.R.T. Release Technology essentially elimina...ent shortening,, Unique anatomically design...urcation,, 0.014 Rapid Exchange catheter wi...ic tip,, Radiopaque marker on catheter clea...
EZ Steer Bi-Directional Catheter
... whole blood assayed hematology control, offers co...ifferential available with the Coulter GENS, STKS,...-vial stability, 105-day closed-vial stability and...4.0ml pierceable cap vial is compatible with all c...
Pilot® Thoracolumbar Pedicle Screw System
Medicine Products: